1. Determinants of tissue estradiol levels and biologic responsiveness in breast tumors

   • Wei Yue
   • Steven J. Santner
   • Richard J. Santen

   OriginalPaper Pages: S1 - S7

2. Biochemical control of breast aromatase

   • A. Singh
   • A. Purohit
   • M.J. Reed

   OriginalPaper Pages: S9 - S14

3. Molecular analysis of aberrant expression of aromatase in breast cancer tissues

   • Nobuhiro Harada
   • Shin-ichiro Honda

   OriginalPaper Pages: S15 - S21

4. Intratumoral aromatase model: The effects of letrozole (CGS 20267)

   • Angela Brodie
   • Qing Lu
   • Yang Liu

   OriginalPaper Pages: S23 - S26

5. Clinical importance of intratumoral aromatase

   • W.R. Miller
   • P. Mullen
   • J.M. Dixon

   OriginalPaper Pages: S27 - S32

6. Discussion

   Legacy Pages: S33 - S37

7. Theoretical considerations for the ideal aromatase inhibitor

   • M. Dowsett

   OriginalPaper Pages: S39 - S44

8. Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer

   • Per E. Lønning

   OriginalPaper Pages: S45 - S52

9. Pharmacological and clinical profile of anastrozole

   • Per E. Lønning
   • Jürgen Geisler
   • Mitch Dowsett

   OriginalPaper Pages: S53 - S57

10. Pre-clinical and clinical review of vorozole, a new third generation aromatase inhibitor

    • Paul E. Goss

    OriginalPaper Pages: S59 - S65

11. Fadrozole and letrozole in advanced breast cancer: Clinical and biochemical effects

    • Ian E. Smith
    • Alison Norton

    OriginalPaper Pages: S67 - S71

12. Discussion

    Legacy Pages: S73 - S77

13. Immunolocalization of aromatase in human breast disorders using different antibodies

    • Hironobu Sasano
    • Hiroshi Murakami

    OriginalPaper Pages: S79 - S84

14. Aromatase expression in the human breast

    • Angela Brodie
    • Brian Long
    • Qing Lu

    OriginalPaper Pages: S85 - S91

15. Demonstration of aromatase activity and its regulation in breast tumor and benign breast fibroblasts

    • R.J. Santen
    • J. Martel
    • S. Santner

    OriginalPaper Pages: S93 - S99

16. Comparison of biochemical aromatase activity with aromatase immunhistochemistry in human breast carcinomas

    • K.C. Shenton
    • M. Dowsett
    • M.G. Rowlands

    OriginalPaper Pages: S101 - S107

17. Dr. Richard Santen's editorial changes to discussion following the Friday morning 11 July 1997 session 'Immunochemical approaches to assessing intratumoral aromatase'

    Legacy Pages: S109 - S120